Authors: Geus, WP Mathot, RAA Mulder, PGH Lamers, CBHW

Citation: Wp. Geus et al., Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40mg during repeated oral administration in Helicobacter pylori-negative subjects, ALIM PHARM, 14(8), 2000, pp. 1057-1064

Authors: Geus, WP

Citation: Wp. Geus, Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?, SC J GASTR, 35, 2000, pp. 10-20

Authors: Geus, WP Eddes, EH Gielkens, HAJ Gan, KH Lamers, CBHW Masclee, AAM

Citation: Wp. Geus et al., Post-prandial intragastric and duodenal acidity are increased in patients with chronic pancreatitis, ALIM PHARM, 13(7), 1999, pp. 937-943

Authors: van Lent-Evers, NAEM Mathot, RAA Geus, WP van Hout, BA Vinks, AATMM

Citation: Naem. Van Lent-evers et al., Impact of goal-oriented and model-based clinical pharmacokinetic dosing ofaminoglycosides on clinical outcome: A cost-effectiveness analysis, THER DRUG M, 21(1), 1999, pp. 63-73

Authors: Mathot, RAA Geus, WP

Citation: Raa. Mathot et Wp. Geus, Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: Characterization of tolerance, CLIN PHARM, 66(2), 1999, pp. 140-151